Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Feb 2026 for Hyperliquid Strategies Inc.
Filing timeline
BuySaleAlbert D. Dyrness
Insider track record
Disclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Albert D. Dyrness: trading record in brief
Albert D. Dyrness (board member) discloses dealings in 2 companies, chiefly Sonnet BioTherapeutics Holdings, Inc. and Hyperliquid Strategies Inc. We count 11 filings; the first trade dates from 1 April 2020 and the latest from 9 February 2026.
Every open-market trade on record is a purchase: 2 purchases worth €19k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 7 share grants.
The record was last updated on 11 February 2026 with a share grant in Hyperliquid Strategies Inc. The last insider purchase was made public on 31 May 2023, 1,242 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Albert D. Dyrness
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
40,789 shares0Common StockSEC:0001193125-26-047187:0
882 sharesCommon StockSEC:0001193125-25-330461:0
4,537 sharesCommon StockSEC:0001493152-25-026062:0
4,000 sharesCommon StockSEC:0001641172-25-019785:0
373 sharesCommon StockSEC:0001493152-24-048956:0
23,255 shares@ US$0.468100.0% of flowCommon StockSEC:0001493152-23-019539:0
Canonical exit: 28 Aug 2023 (T+90)
3,770 sharesCommon StockSEC:0001493152-22-036313:0
14,152 sharesCommon StockSEC:0001493152-22-009486:0
8 of 8 declarations
